Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Cash from Investing Activities (2019 - 2025)

Historic Cash from Investing Activities for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $8.6 million.

  • Outset Medical's Cash from Investing Activities fell 9205.75% to $8.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$97.7 million, marking a year-over-year decrease of 19398.3%. This contributed to the annual value of -$97.7 million for FY2025, which is 19398.3% down from last year.
  • According to the latest figures from Q4 2025, Outset Medical's Cash from Investing Activities is $8.6 million, which was down 9205.75% from $3.0 million recorded in Q3 2025.
  • Over the past 5 years, Outset Medical's Cash from Investing Activities peaked at $108.2 million during Q4 2024, and registered a low of -$97.5 million during Q2 2021.
  • In the last 5 years, Outset Medical's Cash from Investing Activities had a median value of $663500.0 in 2022 and averaged -$6.0 million.
  • In the last 5 years, Outset Medical's Cash from Investing Activities skyrocketed by 216329.79% in 2023 and then crashed by 233348.47% in 2024.
  • Over the past 5 years, Outset Medical's Cash from Investing Activities (Quarter) stood at -$16.4 million in 2021, then crashed by 215.19% to -$51.7 million in 2022, then surged by 145.27% to $23.4 million in 2023, then surged by 361.7% to $108.2 million in 2024, then crashed by 92.06% to $8.6 million in 2025.
  • Its Cash from Investing Activities was $8.6 million in Q4 2025, compared to $3.0 million in Q3 2025 and -$31.2 million in Q2 2025.